Clostridioides Difficile Infection Clinical Trials

45 clinical trials for Clostridioides Difficile Infection across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody — RECRUITING · PHASE2
• Evaluation of EXL01, a New Live Biotherapeutic Product to Prevent Recurrence of Clostridioides Difficile Infection in High-risk Patients — RECRUITING · PHASE1
• VE303 for Prevention of Recurrent Clostridioides Difficile Infection — RECRUITING · PHASE3
• Fecal Microbiota Transplantation in Clostridioides Difficile Infection First Episode and First Recurrence — RECRUITING · PHASE3
• Lifestyle and Recurrent Clostridioides Difficile Infection (CDI) — RECRUITING · NA
• Secondary Prevention of Clostridioides Difficile Using Vancomycin — RECRUITING · PHASE2
• Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population — RECRUITING · PHASE1
• Clostridioides Difficile: Understanding Responses and Treatment Effects — RECRUITING
• FMT in Initial CDI — RECRUITING · NA
• Prevention of Clostridium Difficile Infections Using Lactobacillus Plantarum 299v Strain in Nephrology and Transplantation Department — RECRUITING · NA
• Study of Clostridioides Difficile in Infants — RECRUITING
• Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) — RECRUITING · PHASE2
• Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections — RECRUITING
• Washed Microbiota Transplantation for Clostridioides Difficile Infection — RECRUITING
• LMN-201 for Prevention of C. Difficile Infection Recurrence — ACTIVE_NOT_RECRUITING · PHASE2
• A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides difficile Infection: The RestoratiVE303 Study — TERMINATED · PHASE3
• Long-Term Outcomes After CDI: FMT Versus Antibiotic-Only Treatment — NOT_YET_RECRUITING
• Evaluation of GeoHAI Implementation — ACTIVE_NOT_RECRUITING · NA
• Prevention of Recurrence of Clostridioides Difficile Colitis With Ursodeoxycholic Acid (UCDA) as a Supplement to Standard Therapy — NOT_YET_RECRUITING · PHASE1
• Evaluation of CRS3123 vs. Oral Vancomycin in Adult Patients With Clostridioides Difficile Infection — COMPLETED · PHASE2
• Effect of Oral Microbiota on MDRO Decolonization — COMPLETED · PHASE1
• Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection — COMPLETED · PHASE2
• Xylitol Use for Decolonization of C. Difficile in Patients With IBD — NOT_YET_RECRUITING · PHASE1
• ANtibiotic TReatment OPtimisation – randomised controlled trial of Clostridioides difficile infection therapy (ANTROP-I) — TERMINATED · PHASE2
• Safety and Tolerability of AZD5148 in Japanese Participants — COMPLETED · PHASE1
• Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease — NOT_YET_RECRUITING · PHASE1
• Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease — NOT_YET_RECRUITING · PHASE4
• STOP-CDI: Efficacy of Fecal Microbiota Transplantation vs Fidaxomicin vs Vancomycin in Treating and Preventing Relapse of Clostridioides Difficile Infection — NOT_YET_RECRUITING · NA
• A Flexible Clinical Trial to Test if Freeze-dried Fecal Microbiota Therapy Helps Treat Diarrhea-predominant Irritable Bowel Syndrome or Prevent Recurring C. Difficile Infections. — NOT_YET_RECRUITING · PHASE2
• CMTS0929 for Clostridioides Difficile Infection — NOT_YET_RECRUITING · PHASE1
• Oral Vancomycin Vs Placebo in the Prevention of Recurrence of Clostridioides Difficile's Infection — COMPLETED · PHASE3
• Lyophilized Fecal Microbiome Transfer vs. Vancomycin Monotherapy for Primary Clostridioides Difficile Infection — OTHER · NA
• Ursodeoxycholic Acid in C. Difficile Infection — TERMINATED · NA
• Addressing Personalized Needs in Clostridioides Difficile Infection — COMPLETED · NA
• Clostridioides Difficile Colonisation — OTHER · PHASE1
• L. Plantarum 299v and Gut Microbiome, Diarrhoea, and Clostridioides Difficile Infection in Colorectal Cancer Patients — OTHER · NA
• Safety, Tolerability and the Pharmacokinetics of Ridinilazole in Adolescent Subjects — TERMINATED · PHASE3
• The Characteristics and Role of Mucosal Microbiome After Treatment of Clostridioides Difficile Infection — COMPLETED
• Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection — COMPLETED · PHASE2
• Expanded Access Program of SER-109 in the Treatment of Adults With Recurrent Clostridioides Difficile Infection (RCDI) — OTHER
• ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection — COMPLETED · PHASE3
• Comparison of Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection — COMPLETED · PHASE3
• The Role of Mucosal Microbiome in Recurrence of Clostridioides Difficile Infection — COMPLETED
• The Role of Mucosal Microbiome in the Development, Clearance and Recurrence of Clostridioides Difficile Infection — WITHDRAWN
• Fecal Microbiota Transplantation for Early Clostridioides Difficile Infection — OTHER · NA

Refine this search